Anti-atherogenic effects of fibrates in type 2 diabetes

dc.contributor.authorBarter, Philip Johnen
dc.contributor.schoolSchool of Medicineen
dc.date.issued2001en
dc.identifier.citationCurrent Controlled Trials in Cardiovascular Medicine, 2001; 2(5):218-220en
dc.identifier.issn1468-6708en
dc.identifier.urihttp://hdl.handle.net/2440/33104
dc.language.isoenen
dc.publisherBioMed Central Ltd.en
dc.titleAnti-atherogenic effects of fibrates in type 2 diabetesen
dc.typeJournal articleen

Files